NOBIVAC® Canine 1-DAPPvL2

Canine 1-DAPPvL₂

A proven, combined vaccine that protects dogs against several highly contagious viruses and 2 leptospira serovars.

Product Description

CANINE 1-DAPPvL₂provides protection against commonly spread viruses

Canine Distemper Virus, Canine Adenovirus Type 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), and Leptospira Canicola-Icterohaemorrhagiae (inactivated bacterin).

Protects against all known strains of canine parvovirus (CPV), including CPV-2c^2,3
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- Overrides maternal antibodies in young puppies¹
Defends against 2 strains of Leptospira: L. canicola and L. icterohaemorrhagiae
Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus, in 1 formula

product label

Overview

Administration

Alternate

Disease Information

Resources

Indications:

Shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper virus, canine adenovirus type 1(hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus, Leptospira canicola and Leptospira icterohaemorrhagiae.

Recommended for use in healthy dogs 6 weeks of age or older.

ADMINISTRATION AND DOSAGE

Subcutaneous or intramuscular injection
Two 1 mL doses given 2 to 4 weeks apart
Two doses are required for primary immunization
Contact your veterinarian or manufacturer for more information on revaccination frequency
Available in a 25 x 1 mL dose presentation